Amarillo Biosciences, Inc. (AMAR) has appointed Bernard Cohen as Chief Financial Officer. Mr. Cohen replaces Dr. Gary Coy as CFO, who will assist the company with SEC filings as a consultant.
Previously, Mr. Cohen was Director of Finance and Data Base Manager at Harrington Regional Medical Center in Amarillo. Prior, he held various executive positions at Colbert's department store of Amarillo holding the position of CEO, Vice President, Controller, and Personnel Director. Mr. Cohen currently is a member of the Texas Tech University Institutional Review Board, where he reviews clinical trial protocols to monitor the safety and protection of human subjects.
KNOBIAS DISCLAIMER: All statements made in this article were made by the Company and do not in any way reflect the opinions of Knobias. Knobias is not a registered broker-dealer, nor investment advisor, and does not endorse or recommend any securities mentioned. This story is provided for informational purposes only and is not intended for trading purposes. Knobias shall not be liable for any actions taken in reliance of any information provided herein. Republication or redistribution of Knobias content is expressly prohibited without prior written consent of Knobias.com, LLC.
ABOUT KNOBIAS: Knobias is a premier financial information provider of trading and investing data covering all U.S. equities for investors and security professionals. Knobias is best described by its three major components: Real-time desktop applications providing quotes, charts, level 2, analysis etc.; Knobias RAiDAR providing thousands of real-time news stories, alerts and documents daily; Knobias fundamentals providing a comprehensive database of fundamental research information.
If your company wishes to participate in the EventX newswire, please contact Knobias: http://www.knobias.com
Knobias.com, LLC 601-978-3399 601-978-3675 info@knobias.com www.knobias.com/cmtx

More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index